With the higher dose, pregnant mice demonstrated increased insulin resistance, decreased glucose tolerance, and significantly higher fasting plasma insulin, leptin, triglyceride, and glycerol levels than F0-C mice. This evidence concerns the gene LEP and Insulin resistance.